The clinical tests of the vaccine against COVID-19 developed by the National Center for Epidemiological Research and Microbiology “Gamalei” of Russia have concluded and the registration phase begins, the Russian Minister of Health, Mikhail Murashko, reported on Saturday. “The vaccine against the new coronavirus developed by the Gamalei center has completed clinical trials and documents are now being prepared for registration,” Murashko was quoted by TASS as saying.
…
This website uses cookies.